EXPLAINERText with sources
Mounjaro, which contains the active ingredient tirzepatide, is injected under the skin — including into the abdomen when there is a noticeable layer of fat. We explain what is known about injection sites and why the medicine must not be injected into a muscle.
Checked: 13.11.2026Read ↗ EXPLAINERText with sources
The aim of treatment is not to stop eating. The return of appetite is not a reason to take extra injections. We explain what is known about how Semaglutide works and why more medicine does not mean better treatment.
Article date: 07.11.2026Read ↗ NEW STUDYText with sources
A new analysis from September 2026 concerns body composition and physical function during obesity treatment. Its small size calls for careful interpretation.
Checked: 03.11.2026Read ↗